RBC Capital Maintains Outperform on Johnson & Johnson, Raises Price Target to $181

Benzinga · 10/16 12:37
RBC Capital analyst Shagun Singh maintains Johnson & Johnson (NYSE:JNJ) with a Outperform and raises the price target from $178 to $181.